Report
Dave Nicoski ...
  • Ross LaDuke
EUR 47.11 For Business Accounts Only

Vermilion ETF Pathfinder: Actionable ETF research & Ideas

Bullish Yet Vigilant

In our 6/8/20 ETF Pathfinder we noted a bullish outlook was warranted, but that equities were extended and that we would be buyers on a pullback. Now that markets have pulled back, the question is whether this is just a countertrend move within the ongoing bullish trend, or the beginning of a bigger correction. For now we remain bullish and believe this to be a buyable pullback. Below we highlight key developments we are watching, including what it would take for us to alter our bullish outlook.

· What Would Alter Our Bullish Outlook? Key support levels we are watching include the 2940-2980 zone on the S&P 500, 9500 on the Nasdaq 100 (or $231.50 on the QQQ), and $133 on the Russell 2000 (IWM). A break below these support levels would be a bearish trend change, which would signal additional downside is likely and a more cautious outlook would be warranted. We remain positive as long as these support levels hold... see charts below and page 2.

· Health Care & Consumer Staples. Bullish RS inflections in these Sectors gives us reason for pause as they have been the two pure defensive Sectors amid the coronavirus. Additionally, the last time these two Sectors made similar bullish RS inflections was on February 24, when the coronavirus meltdown began. If outperformance continues for Staples and Health Care, it could spell issues for the broad market... see page 2.

· Actionable Industry ETFs: XBI, BBH, GDX, and SIL... see page 9.

· EM and Int'l: Emerging markets (EEM) and developed int'l (EFA) ETFs are consolidating recent gains; we remain bullish from a price perspective as long as their respective support levels hold... see page 10.

· Actionable Int'l ETFs: EWT, RSXJ, EWN, and EWL..
Underlyings
Global X Silver Miners ETF

iShares MSCI Emerging Markets ETF

iShares MSCI Netherlands ETF

iShares MSCI Switzerland Cappe

iShares MSCI Taiwan ETF

Market Vectors Russia Small-Cap ETF

SPDR S&P Biotech ETF

VanEck Vectors Biotech ETF

VanEck Vectors Gold Miners ETF

Provider
Vermilion Research
Vermilion Research

Vermilion Research delivers timely, actionable, and unique research inputs to professional investors. Our research strategists highlight securities which we believe are at major inflection points, based on our various proprietary technical indicators, and offer asymmetric risk/return profiles. We believe our research methodology, which is not limited by industry sector or market capitalization, enables us to deliver superior investment recommendations.

Our process begins by organizing all actively traded stocks into coherent sectors, then into logical industry groups. We then apply our proprietary relative strength tools to identify developing price trends. Once attractive trends are identified within a selected sectors or groups, we screen for individual stocks which we believe offer the best risk/reward profile. Vermilion offers U.S. and global equity market research products. Vermilion’s research team, which has received numerous awards and accolades, has a combined 70 year of experience in the analysis of investment securities.

Analysts
Dave Nicoski

Ross LaDuke

Other Reports on these Companies
Other Reports from Vermilion Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch